Italy declines to reimburse liraglutide outside a specialist service
Efficacy was never the question in this appraisal. Duration of treatment was.
TheCompound Journal
Reporting on incretins, compounding & the peptide supply chain
Page 21 of 25 of this archive, newest first.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
What the labels permit, what clinicians do, and the size of the gap between them.
The evidence on stopping is better than the evidence on almost anything else in this field, because somebody deliberately randomised it.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
A supply interruption is a discontinuation with no notice, no taper and no plan. That is a distinct clinical situation.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
These agents produce no dependence and no withdrawal syndrome. What a taper would be for is therefore a real question rather than an obvious one.
Efficacy was never the question in this appraisal. Duration of treatment was.
Efficacy was never the question in this appraisal. Duration of treatment was.
Reported from the sessions, and from the two hours afterwards.
Efficacy was never the question in this appraisal. Duration of treatment was.
Cost is the modal reason for discontinuation in every dataset we have seen, and it is absent from the clinical literature.
Reported from the sessions, and from the two hours afterwards.
Reported from the sessions, and from the two hours afterwards.